Skip to main content

Hypoxic-Ischemic Encephalopathy clinical trials at UCSF

3 in progress, 2 open to eligible people

If a baby’s brain doesn’t get enough oxygen or blood, they can develop Hypoxic-Ischemic Encephalopathy (HIE). UCSF is conducting clinical trials to learn more about this condition and improve the outcomes for affected babies. One study is following up with around 300 parent-child groups in the Neonatal Seizure Registry to study genetics. Another study is evaluating outcomes for a group of around 280 children in the registry.

Showing trials for
  • Neonatal Seizure Registry - Developmental Functional EValuation

    open to eligible people ages 2-8

    The NSR-DEV study is a longitudinal cohort study of around 280 Neonatal Seizure Registry participants that aims to evaluate childhood outcomes after acute symptomatic neonatal seizures, as well as examine risk factors for developmental disabilities and whether these are modified by parent well-being.

    San Francisco, California and other locations

  • Neonatal Seizure Registry, GEnetics of Post-Neonatal Epilepsy

    open to all eligible people

    The NSR-GENE study is a longitudinal cohort study of approximately 300 parent-child trios from the Neonatal Seizure Registry and participating site outpatient clinics that aims to evaluate whether and how genes alter the risk of post-neonatal epilepsy among children with acute provoked neonatal seizures. The researchers aim to develop prediction rules to stratify neonates into low, medium, and high risk for post-neonatal epilepsy based on clinical, electroencephalogram (EEG), magnetic resonance imaging (MRI), and genetic risk factors.

    San Francisco, California and other locations

  • TIME Study: Therapeutic Hypothermia for Infants With Mild Encephalopathy

    Sorry, not yet accepting patients

    The TIME study is a randomized, controlled trial to evaluate impact on early measures of neurodevelopment and the safety profile of therapeutic hypothermia in term neonates with Mild Hypoxic-Ischemic Encephalopathy who are < 6 hours of age. Neurodevelopmental outcome will be assessed at 12-14 months of age. The study will enroll 68 neonates randomized to therapeutic hypothermia or normothermia across 5 centers in California.

    Oakland, California and other locations

Our lead scientists for Hypoxic-Ischemic Encephalopathy research studies include .

Last updated: